Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial): A Randomised, Parallel-group, Allocation Concealed, Controlled, Open, Phase 3 Pragmatic Clinical and Cost- Effectiveness Trial With Internal Pilot

NCT03653832 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT03653832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03653832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial): A Randomised, Parallel-group, Allocation Concealed, Controlled, Open, Phase 3 Pragmatic Clinical and Cost- Effectiveness Trial With Internal Pilot
Lead sponsor
University of Edinburgh
Phase
Phase 3
Overall status
Completed
Start date
December 10, 2018
Completion date
July 31, 2024
Enrollment
1,437 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness